Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification.
Source check: Source checked. Not independent scientific confirmation.
Finding: An ensemble of three CNNs classifies drug-resistant TB on 5,039 chest X-rays with an 80/20 split and a further 760-image check, reaching 93.4% test accuracy, plus a usability study with 33 staff. This is a retrospective diagnostic validation of a specific clinical classifier. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: Machine-learning analysis reported for Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning analysis reported for Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification..
- Test and result
- An ensemble of three CNNs classifies drug-resistant TB on 5,039 chest X-rays with an 80/20 split and a further 760-image check, reaching 93.4% test accuracy, plus a usability study with 33 staff. This is a retrospective diagnostic validation of a specific clinical classifier.
- Limitation / still unknown
- The result is limited to the reported study cohort, data split and comparator; external validation was not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1122222/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.